BMP4, bone morphogenetic protein 4, 652

N. diseases: 423; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE Furthermore, ZFP90 affects several oncogenic pathways, including BMP4, and promotes carcinogenesis in patients and in animal models with ZFP90 specific genetic manipulation. 31641208 2020
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE These findings suggest a novel role of BMP4-mediated tumorigenesis in the progression of acquired drug resistance in EGFR-mutant NSCLC cells. 30153566 2018
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE Bone morphogenetic protein-4 (BMP4) plays a crucial role in carcinogenesis, but the effects and signaling mechanisms of BMP4 in hepatocellular carcinoma (HCC) are not clearly clarified. 28543546 2017
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells. 26395571 2015
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE For hepatocellular carcinoma (HCC) only BMP4 and BMP6 are described to be important for carcinogenesis. 22024355 2012
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE Bone morphogenesis protein 4 (BMP4), which belongs to the TGF-β superfamily of proteins, is a multifunctional cytokine, which exerts its biologic effects through SMAD- and non-SMAD-dependent pathways, and is also known to be involved in human carcinogenesis. 22241220 2012
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE Both BMP-4 and RSUME may be interesting targets for inhibiting steps involved in pituitary tumorigenesis. 19407504 2009
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 AlteredExpression phenotype BEFREE Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells. 15197354 2004